Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double-Blind, Placebo-Controlled REGAIN, and Pooled EVOLVE-1 and EVOLVE-2 Studies

Article (Web of Science), Early Access (Web of Science)

• cited authors: Smitherman, Todd A.; Tietjen, Gretchen E.; Schuh, Kory; Skljarevski, Vladimir; Lipsius, Sarah; D'Souza, Deborah N.; Pearlman, Eric M.
• publication date: October 16, 2020
• webpage: Web of Science
• published in: HEADACHE Journal
• category: CLINICAL NEUROLOGY Category

keywords

• anxiety
• comorbid
• depression
• galcanezumab
• migraine
• prevention